Agilent, OGT Expand Partnership to Include Oligonucleotide Microarrays, SureSelect Products | GenomeWeb

By a GenomeWeb staff reporter



NEW YORK (GenomeWeb News) – Agilent Technologies and Oxford Gene Technology today announced an expansion of an existing agreement for the provision of oligonucleotide microarrays and SureSelect target enrichment products to OGT for next-generation sequencing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.